Oliver E. Amin

2.5k total citations
10 papers, 572 citations indexed

About

Oliver E. Amin is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Oliver E. Amin has authored 10 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Oliver E. Amin's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers) and Hepatitis B Virus Studies (3 papers). Oliver E. Amin is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers) and Hepatitis B Virus Studies (3 papers). Oliver E. Amin collaborates with scholars based in United Kingdom, Canada and Switzerland. Oliver E. Amin's co-authors include Mala K. Maini, Laura J. Pallett, Brian R Davidson, Leo Swadling, Alice R. Burton, Kornelija Suveizdytė, Upkar S. Gill, Patrick Kennedy, Claudia Mauri and Laura E. McCoy and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Oliver E. Amin

10 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver E. Amin United Kingdom 7 318 300 227 89 62 10 572
Alice R. Burton United Kingdom 11 522 1.6× 466 1.6× 341 1.5× 128 1.4× 98 1.6× 14 916
Maria Cristina Cavallo Italy 5 403 1.3× 541 1.8× 428 1.9× 154 1.7× 108 1.7× 6 830
Xin-Zi Tang Singapore 8 409 1.3× 209 0.7× 110 0.5× 42 0.5× 33 0.5× 10 611
Natarajan Ayithan United States 12 189 0.6× 156 0.5× 103 0.5× 81 0.9× 97 1.6× 15 387
Kamil Obideen United States 5 320 1.0× 200 0.7× 215 0.9× 99 1.1× 25 0.4× 12 497
Michelle Chung United States 6 145 0.5× 193 0.6× 167 0.7× 45 0.5× 38 0.6× 9 458
Miyako Murakawa Japan 12 146 0.5× 330 1.1× 401 1.8× 45 0.5× 85 1.4× 31 583
Sayuri Nitta Japan 15 170 0.5× 408 1.4× 489 2.2× 51 0.6× 104 1.7× 40 681
Robyn J. Puro United States 7 195 0.6× 254 0.8× 169 0.7× 70 0.8× 41 0.7× 16 475
E. Sanz‐de‐Villalobos Spain 11 170 0.5× 194 0.6× 245 1.1× 91 1.0× 19 0.3× 17 396

Countries citing papers authored by Oliver E. Amin

Since Specialization
Citations

This map shows the geographic impact of Oliver E. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver E. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver E. Amin more than expected).

Fields of papers citing papers by Oliver E. Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver E. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver E. Amin. The network helps show where Oliver E. Amin may publish in the future.

Co-authorship network of co-authors of Oliver E. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver E. Amin. A scholar is included among the top collaborators of Oliver E. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver E. Amin. Oliver E. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grandits, Melanie, Lais C. G. F. Palhares, John W. Devlin, et al.. (2025). Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality. mAbs. 17(1). 2502673–2502673. 1 indexed citations
2.
Diniz, Mariana O., Anna Schurich, Senthil Chinnakannan, et al.. (2022). NK cells limit therapeutic vaccine–induced CD8 + T cell immunity in a PD-L1–dependent manner. Science Translational Medicine. 14(640). eabi4670–eabi4670. 30 indexed citations
3.
Zakeri, Nekisa, Andrew Hall, Leo Swadling, et al.. (2022). Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma. Nature Communications. 13(1). 1372–1372. 78 indexed citations
4.
Kucykowicz, Stephanie, Oliver E. Amin, Alice R. Burton, et al.. (2022). Isolation of human intrahepatic leukocytes for phenotypic and functional characterization by flow cytometry. STAR Protocols. 3(2). 101356–101356. 2 indexed citations
5.
Pallett, Laura J., Xiaoyan Li, Scott Davies, et al.. (2021). The human liver microenvironment shapes the homing and function of CD4 + T-cell populations. Gut. 71(7). 1399–1411. 30 indexed citations
6.
Pallett, Laura J., Alice R. Burton, Oliver E. Amin, et al.. (2020). Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytes. The Journal of Experimental Medicine. 217(9). 81 indexed citations
7.
Swadling, Leo, Laura J. Pallett, Mariana O. Diniz, et al.. (2020). Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence. Cell Reports. 30(3). 687–698.e6. 58 indexed citations
8.
Amin, Oliver E., Emily J. Colbeck, Stéphane Daffis, et al.. (2020). Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators. Hepatology. 74(1). 55–71. 69 indexed citations
9.
Amin, Oliver E., Emily J. Colbeck, Stéphane Daffis, et al.. (2019). FRI-132-In vitro modulation by TLR8 agonist GS-9688 of multiple regulatory cell types in patients with chronic hepatitis B. Journal of Hepatology. 70(1). e445–e445. 1 indexed citations
10.
Burton, Alice R., Laura J. Pallett, Laura E. McCoy, et al.. (2018). Circulating and intrahepatic antiviral B cells are defective in hepatitis B. Journal of Clinical Investigation. 128(10). 4588–4603. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026